Browse EX-10 agreements

SEPARATION AGREEMENT

AND GENERAL RELEASE

This SEPARATION AGREEMENT AND GENERAL RELEASE (“Agreement”), dated as of August 13, 2026, is entered into by and between AIB Data Centers Inc. (the “Company”) and Eyal Rozen (“Executive,” together with the Company, the “Parties” and, each, a “Party”). In consideration of the mutual promises and agreements contained in this Agreement, and other valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:

1. Resignation of Employment. Executive has resigned from the Company and his employment as Chief Operating Officer will be terminated effective August 14, 2026 (the “Termination Date”). Executive will be paid Executive’s regular base salary through the Termination Date. The Company will reimburse Executive for unreimbursed business expenses incurred per existing Company policies, provided such expenses are or have been submitted for reimbursement to the Company in a manner consistent with Company policy no later than the Termination Date.

…

Tai Yuan Hi-Tech Industrial Park

Factory Lease Agreement

This agreement is established between

Lessee, GSI Technology Taiwan Inc (hereinafter referred to as Lessee)

and

Lessor, Tai Yuen Textile Co., Ltd. (hereinafter referred to as Lessor)

for the purpose of reantal of properties in Tai Yuan Hi-Tech Industrial Park. Both parties to this agreement concur to comply with the conditions hereinbelow provided:

| |

…

**PURCHASE AND SALE AGREEMENT **

* *

Low-Income Housing Tax Credit (LIHTC) Transactions for New Development

* *

**

THIS PURCHASE AND SALE AGREEMENT (this “Agreement”) is made and entered into effective as of August 17, 2026 (the “Effective Date”), by and between Norman Berry II Owner, LLC, a Georgia Limited Liability Company (the “Seller”) and Arbour Valley Development, LLC, a Florida Limited Liability Company (the “Purchaser”), and its permitted successors and assigns.

** **

Recitals

WHEREAS, Seller is the sole owner of the Property (as defined on Exhibit A attached hereto) and desires to sell and convey the Property to the Purchaser on the terms contained herein;

WHEREAS, Purchaser desires to purchase the Property from the Seller on the terms contained herein;

…

Exhibit 10.1

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS A TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

EXECUTION VERSION

WOODWARD, INC.

$150,000,000 Series U Senior Notes due September 30, 2029

$150,000,000 Series V Senior Notes due September 30, 2030

$150,000,000 Series W Senior Notes due September 30, 2033

NOTE PURCHASE AGREEMENT

Dated August 19, 2026

---

Table of Contents

Page

…

AMENDED AND RESTATED ADMINISTRATION AGREEMENT

BETWEEN

ANTARES PRIVATE CREDIT FUND

AND

Antares Capital Credit Advisers LLC

This Amended and Restated Administration Agreement (“Agreement”) is made as of August 19, 2026 by and between Antares Private Credit Fund, a Delaware statutory trust (the “Fund”), and Antares Capital Credit Advisers LLC, a Delaware limited liability company (the “Administrator”).

WHEREAS, the Fund and the Administrator entered into an Administration Agreement dated as of October 31, 2024 (the “Prior Agreement”);

WHEREAS, in connection with the registration of the shares of the Fund in certain states, certain state securities regulators have required modifications to the Prior Agreement; and

WHEREAS, the Fund and the Administrator desire to accordingly amend and restate the Prior Agreement in its entirety, as set forth herein.

…

AMended and RESTATED INVESTMENT ADVISORY AGREEMENT

This Amended and Restated Investment Advisory Agreement, dated and effective as of August 19, 2026, is made by and between Antares Private Credit Fund, a Delaware statutory trust (herein referred to as the “Fund”), and Antares Capital Credit Advisers LLC, a Delaware limited liability company (herein referred to as the “Adviser”) (this “Agreement”).

WHEREAS, the Fund and the Adviser entered into an Investment Advisory Agreement dated as of October 31, 2024 (the “Prior Agreement”); and

WHEREAS, in connection with the registration of the shares of the Fund in certain states, state securities regulators have required non-material modifications to the Prior Agreement; and

WHEREAS, the Fund and the Adviser desire to accordingly amend and restate the Prior Agreement in its entirety, as set forth herein.

…

SKY QUARRY, INC.

Employment** Offer **Letter

August 17, 2026

Heidi Bowman** [***]**

[***]

Dear Ms. Bowman,

Sky Quarry, Inc. (NASDAQ: SKYQ) (the "Company") is pleased to extend this offer of employment to you on the terms and conditions set forth in this letter (this "Agreement"). This Agreement is entered into between Sky Quarry, Inc. and Heidi Bowman ("Employee") effective as of August 18, 2026.

1.Position and Duties

…

LOCK-UP AGREEMENT

[•], 2026

Werewolf Therapeutics, Inc.

303 Wyman Street, Suite 300

Waltham, MA 02451

Attention: Legal Department

Email: [***]

Ladies and Gentlemen:

The undersigned signatory of this lock-up agreement (this “Lock-Up Agreement”) understands that Werewolf Therapeutics, Inc., a Delaware corporation (“Werewolf”), has entered into an Agreement and Plan of Merger, dated as of August 21, 2026 (as the same may be amended from time to time, the “Merger Agreement”) with Ambros Therapeutics, Inc., a Delaware corporation (“Ambros”), and Wave Atlantis Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Werewolf. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement.

…

**CONTINGENT VALUE RIGHTS AGREEMENT **

THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [•], 202[•] (this “Agreement”), is entered into by and among WEREWOLF THERAPEUTICS, INC.,** **a Delaware corporation (“Werewolf”), and [•] (the “Rights Agent” and, collectively with Werewolf, the “Parties”).

**RECITALS **

WHEREAS, Ambros Therapeutics, Inc., a Delaware corporation (“Ambros”), Werewolf, and Wave Atlantis Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Werewolf (“Merger Sub”) have entered into an Agreement and Plan of Merger dated as of August 21, 2026 (as it may be amended or supplemented from time to time pursuant to the terms thereof, the “Merger Agreement”), pursuant to which Merger Sub will merge with and into Ambros (the “Merger”), with Ambros surviving the Merger as a wholly owned subsidiary of Werewolf; and

…

**STOCKHOLDER SUPPORT AGREEMENT **

This Support Agreement (this “Support Agreement”) is being delivered on August 21, 2026 by the person or persons named on the signature pages hereto (collectively, the “Holder”), as the holder of Werewolf Shares (as defined below) of Werewolf Therapeutics, Inc., a Delaware corporation (“Werewolf”), to Ambros Therapeutics, Inc., a Delaware corporation (“Ambros”) and to Werewolf.

Reference is made to that certain Agreement and Plan of Merger (the “Merger Agreement”), as amended from time to time, dated as of August 21, 2026, by and among Ambros, Werewolf and Merger Sub. All capitalized terms that are used but not defined herein shall have the respective meanings ascribed to them in the Merger Agreement.

…

**STOCKHOLDER SUPPORT AGREEMENT **

This Support Agreement (this “Support Agreement”) is being delivered on August 21, 2026 by the person or persons named on the signature pages hereto (collectively, the “Holder”), as the holder of Ambros Shares (as defined below) of Ambros Therapeutics, Inc., a Delaware corporation (“Ambros”), to Werewolf Therapeutics, Inc., a Delaware corporation (“Werewolf”).

Reference is made to that certain Agreement and Plan of Merger (the “Merger Agreement”), as amended from time to time, dated as of August 21, 2026, by and among Ambros, Werewolf and Wave Atlantis Merger Sub, Inc. (“Merger Sub”). All capitalized terms that are used but not defined herein shall have the respective meanings ascribed to them in the Merger Agreement.

…

**SECURITIES PURCHASE AGREEMENT **

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of August 21, 2026, by and among Werewolf Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, concurrently with the execution and delivery of this Agreement, the Company is entering into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Wave Atlantis Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (“Merger Sub”), and Ambros Therapeutics, Inc., a Delaware corporation (“Ambros”), pursuant to which Merger Sub will merge with and into Ambros, with Ambros surviving as a wholly owned subsidiary of the Company (the “Merger”), in each case in accordance with and subject to the terms and conditions set forth in the Merger Agreement;

…